DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+33.56%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.42B
AUM Growth
+$5.42B
(+19%)
Cap. Flow
+$277M
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
57.84%
Holding
242
New
154
Increased
21
Reduced
12
Closed
14
Top Buys
| 1 |
Oscar Health
OSCR
|
$103M |
| 2 |
Baxter International
BAX
|
$52.5M |
| 3 |
Revolution Medicines
RVMD
|
$38.4M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$36.7M |
| 5 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$34.4M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$41.2M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$38.5M |
| 3 |
Merus
MRUS
|
$23.6M |
| 4 |
Owens & Minor
OMI
|
$23.2M |
| 5 |
Roivant Sciences
ROIV
|
$18.7M |
Sector Composition
| 1 | Healthcare | 78.16% |
| 2 | Technology | 0.1% |
| 3 | Industrials | 0.09% |
| 4 | Consumer Discretionary | 0.08% |
| 5 | Consumer Staples | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
ON24
ONTF
$242M
| $236K | ﹤0.01% |
+30,009
| New | +$236K |
|
152
Select Water Solutions
WTTR
$895M
| $236K | ﹤0.01% |
+31,083
| New | +$236K |
|
153
MaxCyte
MXCT
$148M
| $235K | ﹤0.01% |
+50,031
| New | +$235K |
|
154
Zimmer Biomet
ZBH
$21B
| $233K | ﹤0.01% |
+1,918
| New | +$233K |
|
155
Becton Dickinson
BDX
$55.3B
| $231K | ﹤0.01% |
+949
| New | +$231K |
|
156
Illinois Tool Works
ITW
$77.1B
| $220K | ﹤0.01% |
+838
| New | +$220K |
|
157
Warner Bros
WBD
$28.8B
| $219K | ﹤0.01% |
+19,201
| New | +$219K |
|
158
Terreno Realty
TRNO
$5.97B
| $216K | ﹤0.01% |
+3,452
| New | +$216K |
|
159
Dominion Energy
D
$51.1B
| $211K | ﹤0.01% |
+4,495
| New | +$211K |
|
160
Golub Capital BDC
GBDC
$3.97B
| $211K | ﹤0.01% |
+13,955
| New | +$211K |
|
161
Main Street Capital
MAIN
$5.93B
| $210K | ﹤0.01% |
+4,856
| New | +$210K |
|
162
Ambac
AMBC
$419M
| $209K | ﹤0.01% |
+12,673
| New | +$209K |
|
|
ITCI
163
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $208K | ﹤0.01% |
+2,910
| New | +$208K |
|
164
Forward Air
FWRD
$925M
| $207K | ﹤0.01% |
+3,294
| New | +$207K |
|
165
Kohl's
KSS
$1.69B
| $207K | ﹤0.01% |
+7,207
| New | +$207K |
|
166
MGE Energy Inc
MGEE
$3.11B
| $207K | ﹤0.01% |
+2,856
| New | +$207K |
|
167
Aris Water Solutions
ARIS
$794M
| $206K | ﹤0.01% |
+24,554
| New | +$206K |
|
168
Vital Energy
VTLE
$690M
| $205K | ﹤0.01% |
+4,512
| New | +$205K |
|
169
Hewlett Packard
HPE
$29.6B
| $204K | ﹤0.01% |
+12,031
| New | +$204K |
|
170
OrthoPediatrics
KIDS
$536M
| $202K | ﹤0.01% |
+6,200
| New | +$202K |
|
171
Exelixis
EXEL
$10.1B
| $202K | ﹤0.01% |
+8,400
| New | +$202K |
|
172
Broadcom
AVGO
$1.4T
| $201K | ﹤0.01% |
+180
| New | +$201K |
|
173
ADMA Biologics
ADMA
$4.12B
| $193K | ﹤0.01% |
+42,657
| New | +$193K |
|
174
Huntington Bancshares
HBAN
$26B
| $187K | ﹤0.01% |
+14,701
| New | +$187K |
|
175
N-able
NABL
$1.51B
| $185K | ﹤0.01% |
+13,937
| New | +$185K |
|